Serum concentration and kidney expression of salusin-α and salusin-β in rats with metabolic syndrome induced by fructose

Biotechnic and Histochemistry

Volumn 88, Issue 3-4, 2013, Pages 153-160

  Sahin, I ^a,b   Aydin, S ^b  

^a ERZINCAN UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Immunohistochemistry; Kidney; Metabolic syndrome; Salusins

Indexed keywords

FRUCTOSE; LIPID; SALUSIN BETA, RAT; SALUSIN-BETA, RAT; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; BLOOD; CARBOHYDRATE DIET; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; METABOLIC SYNDROME X; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; DIETARY CARBOHYDRATES; DISEASE MODELS, ANIMAL; FRUCTOSE; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; LIPIDS; MALE; METABOLIC SYNDROME X; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

ANIMALIA; RATTUS;

EID: 84876467694     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2012.744848     Document Type: Article

References (36)

1. Al-Sarraj T, Saadi H, Volek JS, Fernandez ML (2010) Carbohydrate restriction favorably alters lipoprotein metabolism in Emirati subjects classif ed with the metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 20: 720-726.
2. Aydin S (2011) Effects of cardiopulmonary bypass on expression of apelin and salusin and i nvestigation of whether or not they are locally synthesized in the aorta, saphenous vein and artery graft. Specialization Thesis in Medicine. Dicle University, Diyarbakir, Turkey.
3. Aydin S, Eren MN, Aydin S (2012a) Physiology and clinical role of salusin-α and β peptides in the cardiovascular system. Turkiye Klinikleri J. Cardiovasc. Sci. In press.
4. Aydin S, Eren MN, Aydin S, Ozercan IH, Dagli AF (2012b) The bioactive peptides salusins and apelin-36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass. Peptides 37: 233-239.
5. Balkau B, Valensi P, Eschwège E, Slama G (2007) A review of the metabolic syndrome. Diabetes Metab. 33: 405-413.
6. Bantle JP, Raatz SK, Thomas W, Georgopoulos A (2000) Effects of dietary fructose on plasma lipids in healthy subjects. Am. J. Clin. Nutr. 72: 1128-1134.
7. Bray GA, Nielsen SJ, Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 79: 537-543. (Pubitemid 41103894)
8. Bruce KD, Byrne CD (2009) The metabolic syndrome: common origins of a multifactorial disorder. Postgrad. Med. J. 85: 614-621.
9. Catak Z (2012) Investigation of serum and gonadal ghre-lin, obestatin, nesfatin-1 expression in rats with fructose-induced metabolic syndrome. Specialization Thesis in Medicine. Firat University, Elazig, Turkey.
10. Dabrowska-Zamojcin E, Pawlik A, Domański L, Rózaóski J, Droździk M (2005) Cyclosporine and sirolimus interaction in a kidney transplant patient. Transplant. Proc. 37: 2317-2319. (Pubitemid 40956440)
11. Dagli AF, Aydin S, Karaoglu A, Akpolat N, Ozercan IH, Ozercan MR (2009) Ghrelin expression in normal kidney tissue and renal carcinomas. Pathol. Res. Pract. 205: 165-173.
12. Drewa T, Wolski Z, Gruszka M, Misterek B, Lysik J (2007) Uric acid plasma level and urine pH in rats treated with ambroxol. Acta Pol. Pharm. 64: 565-567. (Pubitemid 351360390)
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
14. Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS (2010) High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care 33: 1337-1343.
15. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: f ndings from the Third National Health and Nutrition Examination Survey. JAMA 287: 356-359. (Pubitemid 34251969)
16. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
17. Gajda AM, Pellizzon MA, Ricci MR, Edward A (2007) Diet-induced metabolic syndrome in rodent models. Animal LAB News: A Discussion of How Diets Made from Purif ed Ingredients Inf uence the Phenotypes of the MS in Commonly Used Rodent Models. http://www.research-diets.com/OSD/DIDM/metabolic.htm, 10 subat 2012.
18. Gerritsen KG, Peters HP, Nguyen TQ, Koeners MP, Wetzels JF, Joles JA, Christensen EI, Verroust PJ, Li D, Oliver N, Xu L, Kok RJ, Goldschmeding R (2010) Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion. Am. J. Physiol. Renal. Physiol. 298: F1457-F1464.
19. Handelsman Y (2009) Metabolic syndrome pathophysiology and clinical presentation. Toxicol. Pathol. 37: 18-20.
20. Hsu SM, Raine L, Fanger H (1981) Use of avidin-Biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577-580. (Pubitemid 11147380)
21. Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A (2010) Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif. 30: 288-295.
22. Koya T, Miyazaki T, Watanabe T, Shichiri M, Atsumi T, Kim-Kaneyama JR, Miyazaki A (2012) Salusin-fj accelerates oxidative stress in vascular endothelial cells. Signaling in LDL receptor-def cient mice in vivo and HUVECs in vitro. Am. J. Physiol. Heart Circ. Physiol. 303: H96-H105.
23. Kuloglu T, Dabak DO (2009) Determination of ghrelin immunoreactivity in kidney tissues of diabetic rats. Renal Fail. 31: 562-566.
24. Lee CC, Lee RP, Subeq YM, Wang CH, Fang TC, Hsu BG (2008) Fasting serum total ghrelin level inversely correlates with metabolic syndrome in hemodialysis patients. Arch. Med. Res. 39: 785-790.
25. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ (2006) A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal Physiol. 290: 625-631.
26. Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D (2008) Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr. Hypertens. Rep. 10: 131-137.
27. Sahin I, Aydin S, Ozkan Y, Dagli AF, Akin KO, Guzel SP, Catak Z, Ozercan MR (2011) Diet-induced obesity suppresses ghrelin in rat gastrointestinal tract and serum. Mol. Cell. Biochem. 355: 299-308.
28. Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M (2007) Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvas-cular damage in rats. Am. J. Physiol. Renal Physiol. 292: 423-429.
29. Sato K, Koyama T, Tateno T, Hirata Y, Shichiri M (2006) Presence of immunoreactive salusin-alpha in human serum and urine. Peptides 27: 2561-2566. (Pubitemid 44584413)
30. Sato K, Fujimoto K, Koyama T, Shichiri M (2010) Release of salusin-beta from human monocytes/macrophages. Regul. Pept. 162: 68-72.
31. Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, Hirata Y (2003) Salusins newly identif ed bioactive peptides with hemodynamic and mitogenic activities. Nat. Med. 9: 1166-1172. (Pubitemid 37173701)
32. Shu KH, Tsai IC, Ho HC, Wu MJ, Chen CH, Cheng CH, Yu TM, Chuang YW, Huang ST (2012) Serum adiponec-tin levels in renal transplant recipients with and without metabolic syndrome. Transplant. Proc. 44: 676-679.
33. Soleimani M (2011) Dietary fructose, salt absorption and hypertension in metabolic syndrome: towards a new paradigm. Acta Physiol. (Oxf.) 201: 55-62.
34. Tran LT, Yuen VG, McNeill JH (2009) The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol. Cell. Biochem. 332: 145-159.
35. Tsai JC, Chang WY, Kao CC, Lu MS, Chen YJ, Chan P (2002) Benef cial effect on blood pressure and lipid profile by programmed exercise training in Taiwanese patients with mild hypertension. Clin. Exp. Hypertens. 24: 315-324. (Pubitemid 34602705)
36. Watanabe T, Nishio K, Kanome T, Matsuyama TA, Koba S, Sakai T, Sato K, Hongo S, Nose K, Ota H, Kobayashi Y, Katagiri T, Shichiri M, Miyazaki A (2008) Impact of salusin-α and-β on human macrophage foam cell formation and coronary atherosclerosis. Circulation 117: 638-648.